{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:46:23Z","timestamp":1787507183080,"version":"build-2736575974"},"reference-count":129,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministerio de Ciencia e Innovaci\u00f3n","award":["PID2021-123076OB-I00"],"award-info":[{"award-number":["PID2021-123076OB-I00"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n","award":["AENC1\/22-29754"],"award-info":[{"award-number":["AENC1\/22-29754"]}]},{"DOI":"10.13039\/501100002911","name":"Programa Operativo de Empleo Juvenil from Comunidad de Madrid","doi-asserted-by":"publisher","award":["PID2021-123076OB-I00"],"award-info":[{"award-number":["PID2021-123076OB-I00"]}],"id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002911","name":"Programa Operativo de Empleo Juvenil from Comunidad de Madrid","doi-asserted-by":"publisher","award":["AENC1\/22-29754"],"award-info":[{"award-number":["AENC1\/22-29754"]}],"id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Investigo from Comunidad de Madrid","award":["PID2021-123076OB-I00"],"award-info":[{"award-number":["PID2021-123076OB-I00"]}]},{"name":"Programa Investigo from Comunidad de Madrid","award":["AENC1\/22-29754"],"award-info":[{"award-number":["AENC1\/22-29754"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for their clinical management. One of the common pathophysiological alterations that underlies both diseases is oxidative stress (OxS), which appears as a result of lipid deposition in affected tissues. However, the molecular mechanisms that lead to OxS generation are different in each disease. Non-coding RNAs (ncRNAs) are RNA transcripts that do not encode proteins and function by regulating gene expression. In recent years, the involvement of ncRNAs in OxS modulation has become more recognized. This review summarizes the most recent advances regarding ncRNA-mediated regulation of OxS in atherosclerosis and NAFLD. In both diseases, ncRNAs can exert pro-oxidant or antioxidant functions by regulating gene targets and even other ncRNAs, positioning them as potential therapeutic targets. Interestingly, both diseases have common altered ncRNAs, suggesting that the same molecule can be targeted simultaneously when both diseases coexist. Finally, since some ncRNAs have already been used as therapeutic agents, their roles as potential drugs for the clinical management of atherosclerosis and NAFLD are analyzed.<\/jats:p>","DOI":"10.3390\/antiox12020262","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:53:18Z","timestamp":1674618798000},"page":"262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-6538","authenticated-orcid":false,"given":"Jorge","family":"Infante-Men\u00e9ndez","sequence":"first","affiliation":[{"name":"Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-0172","authenticated-orcid":false,"given":"Paula","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-6481","authenticated-orcid":false,"given":"Raquel","family":"Huertas-L\u00e1rez","sequence":"additional","affiliation":[{"name":"Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"G\u00f3mez-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-1645","authenticated-orcid":false,"given":"\u00d3scar","family":"Escribano","sequence":"additional","affiliation":[{"name":"Hepatic and Vascular Diseases Laboratory, Biochemistry and Molecular Biology Department, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative Stress and the Pathogenesis of Alzheimer\u2019s Disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"W\u0142odarski, A., Strycharz, J., Wr\u00f3blewski, A., Kasznicki, J., Drzewoski, J., and \u015aliwi\u0144ska, A. (2020). The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186902"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8267234","DOI":"10.1155\/2019\/8267234","article-title":"Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases","volume":"2019","author":"Vona","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Malekmohammad, K., Sewell, R.D.E., and Rafieian-Kopaei, M. (2019). Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules, 9.","DOI":"10.3390\/biom9080301"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vascul. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms16010378","article-title":"Oxidative Stress in Obesity: A Critical Component in Human Diseases","volume":"16","author":"Marseglia","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/ijms12053117","article-title":"Inflammation, Oxidative Stress, and Obesity","volume":"12","author":"Bautista","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ziolkowska, S., Binienda, A., Jab\u0142kowski, M., Szemraj, J., and Czarny, P. (2021). The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011128"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ecn.2018.0415","article-title":"Obesity and inflammation","volume":"29","author":"Karczewski","year":"2018","journal-title":"Eur. Cytokine Netw."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative Stress in Atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"Rubio","year":"2003","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1440-1746.2004.03562.x","article-title":"Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease","volume":"19","author":"Macdonald","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tello-Flores, V.A., Beltr\u00e1n-Anaya, F.O., Ram\u00edrez-Vargas, M.A., Esteban-Casales, B.E., Navarro-Tito, N., Alarc\u00f3n-Romero, L.D.C., Luciano-Villa, C.A., Ram\u00edrez, M., del Moral-Hern\u00e1ndez, \u00d3., and Flores-Alfaro, E. (2021). Role of Long Non-Coding RNAs and the Molecular Mechanisms Involved in Insulin Resistance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147256"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","article-title":"Non-coding RNAs: Classification, Biology and Functioning","volume":"Volume 937","author":"Hombach","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"107715","DOI":"10.1016\/j.pharmthera.2020.107715","article-title":"Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers","volume":"220","author":"Saaoud","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rusu, I., Pirlog, R., Chiroi, P., Nutu, A., Puia, V.R., Fetti, A.C., Rusu, D.R., Berindan-Neagoe, I., and Al Hajjar, N. (2022). The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012370"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: Diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref_26","first-page":"2537","article-title":"Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq","volume":"117","author":"Vallejo","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_27","first-page":"129","article-title":"Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs","volume":"95","author":"Ginckels","year":"2022","journal-title":"Yale J. Biol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Infante-Men\u00e9ndez, J., L\u00f3pez-Pastor, A.R., Gonz\u00e1lez-L\u00f3pez, P., G\u00f3mez-Hern\u00e1ndez, A., and Escribano, O. (2020). The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications. Antioxidants, 9.","DOI":"10.3390\/antiox9070607"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","article-title":"Activation of Nrf2\/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume":"34","author":"Zhang","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41569-019-0239-5","article-title":"Endothelial responses to shear stress in atherosclerosis: A novel role for developmental genes","volume":"17","author":"Souilhol","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cvr\/cvz203","article-title":"Non-coding RNAs in cardiovascular cell biology and atherosclerosis","volume":"115","author":"Fasolo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15652","DOI":"10.1074\/jbc.M608318200","article-title":"Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase","volume":"282","author":"Fish","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8245810","DOI":"10.1155\/2019\/8245810","article-title":"LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX","volume":"2019","author":"Wang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.febslet.2015.08.046","article-title":"The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT","volume":"589","author":"Tang","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_35","first-page":"4645","article-title":"Inhibition of miR-34a prevents endothelial cell apoptosis by directly targeting HDAC1 in the setting of atherosclerosis","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_36","first-page":"2237","article-title":"MicroRNA-155 affects oxidative damage through regulating autophagy in endothelial cells","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/cdd.2011.42","article-title":"MiR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition","volume":"18","author":"Magenta","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"671461","DOI":"10.3389\/fcell.2021.671461","article-title":"MicroRNA-494 Regulates Endoplasmic Reticulum Stress in Endothelial Cells","volume":"9","author":"Chatterjee","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mam.2018.03.002","article-title":"ROS signaling and ER stress in cardiovascular disease","volume":"63","author":"Ochoa","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00059-019-4790-y","article-title":"Immunity and inflammation in atherosclerosis","volume":"44","author":"Wolf","year":"2019","journal-title":"Herz"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9972413","DOI":"10.1155\/2021\/9972413","article-title":"BTK Promotes Atherosclerosis by Regulating Oxidative Stress, Mitochondrial Injury, and ER Stress of Macrophages","volume":"2021","author":"Qiu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8563845","DOI":"10.1155\/2019\/8563845","article-title":"Targeting early atherosclerosis: A focus on oxidative stress and inflammation","volume":"2019","author":"Marchio","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2004.06.030","article-title":"Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development","volume":"37","author":"Aviram","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/CIRCRESAHA.114.302153","article-title":"Macrophage Mitochondrial Oxidative Stress Promotes Atherosclerosis and Nuclear Factor-\u03baB\u2013Mediated Inflammation in Macrophages","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Grechko, A.V., Orekhova, V.A., Chegodaev, Y.S., Wu, W.-K., and Orekhov, A.N. (2020). Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology, 9.","DOI":"10.3390\/biology9030060"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"155912","DOI":"10.1016\/j.cyto.2022.155912","article-title":"LncRNA KCNQ1OT1 knockdown inhibits ox-LDL-induced inflammatory response and oxidative stress in THP-1 macrophages through the miR-137\/TNFAIP1 axis","volume":"155","author":"Xu","year":"2022","journal-title":"Cytokine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11010-020-03962-w","article-title":"GAS5 knockdown suppresses inflammation and oxidative stress induced by oxidized low-density lipoprotein in macrophages by sponging miR-135a","volume":"476","author":"Zhang","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1002\/jcp.27317","article-title":"Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox-LDL-treated human macrophages by upregulating miR-330-5p","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/jcb.27541","article-title":"NEAT1 contributes to ox-LDL-induced inflammation and oxidative stress in macrophages through inhibiting miR-128","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14154","DOI":"10.1002\/jcp.28109","article-title":"LncRNA UCA1 sponges miR-206 to exacerbate oxidative stress and apoptosis induced by ox-LDL in human macrophages","volume":"234","author":"Hu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4942519","DOI":"10.1155\/2022\/4942519","article-title":"LncRNA260 siRNA Accelerates M2 Macrophage Polarization and Alleviates Oxidative Stress via Inhibiting IL28RA Gene Alternative Splicing","volume":"2022","author":"Yang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wang, X., and Bai, M. (2021). CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206\/ASPH axis in atherosclerosis cell model in vitro. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-020-01800-x"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1002\/jcb.26819","article-title":"MiR-135a represses oxidative stress and vascular inflammatory events via targeting toll-like receptor 4 in atherogenesis","volume":"119","author":"Du","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","article-title":"MicroRNA-21\u2013Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload","volume":"143","author":"Ramanujam","year":"2021","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"107881","DOI":"10.1016\/j.celrep.2020.107881","article-title":"Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo","volume":"32","author":"Bouchareychas","year":"2020","journal-title":"Cell Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kattoor, A.J., Goel, A., and Mehta, J.L. (2019). LOX-1: Regulation, signaling and its role in atherosclerosis. Antioxidants, 8.","DOI":"10.3390\/antiox8070218"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01660974","article-title":"Composition and classification of human atherosclerotic lesions","volume":"421","author":"Stary","year":"1992","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13036-021-00281-6","article-title":"Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197\/COX10 axis","volume":"16","author":"Zhang","year":"2022","journal-title":"J. Biol. Eng."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00441-020-03338-y","article-title":"Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL","volume":"383","author":"Wang","year":"2021","journal-title":"Cell Tissue Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113303","DOI":"10.1016\/j.yexcr.2022.113303","article-title":"Angiotensin II-induced miR-31-5p upregulation promotes vascular smooth muscle cell proliferation and migration","volume":"419","author":"Zhou","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11906-006-0050-7","article-title":"Inflammation and the metabolic syndrome: Role of angiotensin II and oxidative stress","volume":"8","author":"Ferder","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbadis.2015.04.012","article-title":"miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells","volume":"1852","author":"Yang","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.08.023","article-title":"MicroRNA-24 inhibits the oxidative stress induced by vascular injury by activating the Nrf2\/Ho-1 signaling pathway","volume":"290","author":"Zhang","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/ars.2017.7005","article-title":"Inhibition of miR-92a Suppresses Oxidative Stress and Improves Endothelial Function by Upregulating Heme Oxygenase-1 in db\/db Mice","volume":"28","author":"Gou","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","article-title":"MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2","volume":"15","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"s10020","DOI":"10.1186\/s10020-022-00547-9","article-title":"miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3\/PIK3R1\/Akt pathway and induces endothelial cell injury and lipid accumulation","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/CIRCRESAHA.120.318688","article-title":"CARMN Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice","volume":"128","author":"Vacante","year":"2021","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jia, C., Xiong, M., Wang, P., Cui, J., Du, X., Yang, Q., Wang, W., Chen, Y., and Zhang, T. (2014). Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model. PLoS One, 9.","DOI":"10.1371\/journal.pone.0099849"},{"key":"ref_70","first-page":"2261854","article-title":"Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Healthc. Eng."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Albano, E., and Parola, M. (2015). Studies on Hepatic Disorders, Springer International Publishing.","DOI":"10.1007\/978-3-319-15539-5"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","article-title":"Mitochondrial abnormalities in non-alcoholic steatohepatitis","volume":"31","author":"Caldwell","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cca.2011.04.013","article-title":"The role of oxidative stress in non-alcoholic steatohepatitis","volume":"412","author":"Koek","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/002215540104900508","article-title":"The role of 15-lipoxygenase in disruption of the peroxisomal membrane and in programmed degradation of peroxisomes in normal rat liver","volume":"49","author":"Yokota","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Nasc\u00e8, A., Gariani, K., Jornayvaz, F.R., and Szanto, I. (2022). NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants, 11.","DOI":"10.3390\/antiox11061131"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ma, Y., Lee, G., Heo, S.-Y., and Roh, Y.-S. (2021). Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11010091"},{"key":"ref_81","first-page":"G408","article-title":"Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21","volume":"317","author":"Albadrani","year":"2019","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Brankovi\u0107, M., Jovanovi\u0107, I., Duki\u0107, M., Radonji\u0107, T., Opri\u0107, S., Kla\u0161nja, S., and Zdravkovi\u0107, M. (2022). Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095146"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bhattacharjee, S., and Dashwood, R.H. (2020). Epigenetic Regulation of NRF2\/KEAP1 by Phytochemicals. Antioxidants, 9.","DOI":"10.3390\/antiox9090865"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2022.06.226","article-title":"Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2","volume":"188","author":"Bathish","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-5996-3-17","article-title":"Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats","volume":"3","author":"Noeman","year":"2011","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbrc.2018.02.115","article-title":"SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation","volume":"498","author":"Pan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/10715762.2019.1635691","article-title":"Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients","volume":"53","author":"Maciejczyk","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/iub.2221","article-title":"Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway","volume":"72","author":"Teimouri","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.redox.2018.07.002","article-title":"Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1\/Nrf2 pathway","volume":"18","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1096\/fj.201802015R","article-title":"Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression","volume":"33","author":"Kumar","year":"2019","journal-title":"FASEB J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hbpd.2019.05.002","article-title":"miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes","volume":"18","author":"Wang","year":"2019","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100409","DOI":"10.1016\/j.jhepr.2021.100409","article-title":"Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance","volume":"4","author":"Johnson","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Yang, Y.-L., Kuo, H.-C., Wang, F.-S., and Huang, Y.-H. (2019). MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061499"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Wang, F.S., Yang, Y.L., and Huang, Y.H. (2019). MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Cells, 8.","DOI":"10.3390\/cells8101298"},{"key":"ref_97","first-page":"G298","article-title":"Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis","volume":"308","author":"Dattaroy","year":"2015","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"22522","DOI":"10.1021\/acsomega.2c01801","article-title":"Identify Functional lncRNAs in Nonalcoholic Fatty Liver Disease by Constructing a ceRNA Network","volume":"7","author":"Xue","year":"2022","journal-title":"ACS Omega"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"889858","DOI":"10.3389\/fendo.2022.889858","article-title":"LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p\/PDE4B to Activate cAMP\/CREB Pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8515343","DOI":"10.1155\/2018\/8515343","article-title":"miR-26a potentially contributes to the regulation of fatty acid and sterol metabolism in vitro human HepG2 cell model of nonalcoholic fatty liver disease","volume":"2018","author":"Ali","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3960197","article-title":"circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis","volume":"2017","author":"Guo","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.18632\/aging.104081","article-title":"Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179\/miR-188-3p\/GPX4 signaling","volume":"12","author":"Yang","year":"2020","journal-title":"Aging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1080\/21655979.2021.2017698","article-title":"MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4853355","DOI":"10.1155\/2021\/4853355","article-title":"MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPK\u03b1","volume":"2021","author":"Yu","year":"2021","journal-title":"Anal. Cell. Pathol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1007\/s11033-022-07515-w","article-title":"MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1","volume":"49","author":"Ding","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of Genome Size on AAV Vector Packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.00209-12","article-title":"The Threefold Protrusions of Adeno-Associated Virus Type 8 Are Involved in Cell Surface Targeting as Well as Postattachment Processing","volume":"86","author":"Raupp","year":"2012","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100300","DOI":"10.1016\/j.jhepr.2021.100300","article-title":"Novel vectors and approaches for gene therapy in liver diseases","volume":"3","author":"Maestro","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_110","first-page":"1230","article-title":"MicroRNA-802 increases hepatic oxidative stress and induces insulin resistance in high-fat fed mice","volume":"20","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1002\/jcp.28450","article-title":"Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00335-022-09945-0","article-title":"RMRP inhibition prevents NAFLD progression in rats via regulating miR-206\/PTPN1 axis","volume":"33","author":"Yin","year":"2022","journal-title":"Mamm. Genome"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"eaaw9709","DOI":"10.1126\/scitranslmed.aaw9709","article-title":"Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance","volume":"12","author":"Azzimato","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/iub.2137","article-title":"Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization","volume":"71","author":"Wang","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: Global epidemiology and pathogenesis","volume":"15","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Hu","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Zogg, H., Singh, R., and Ro, S. (2022). Current Advances in RNA Therapeutics for Human Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052736"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.110.005108","article-title":"Flow-dependent regulation of kr\u00fcppel-like factor 2 is mediated by MicroRNA-92a","volume":"124","author":"Wu","year":"2011","journal-title":"Circulation"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.114.302213","article-title":"Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice","volume":"114","author":"Loyer","year":"2014","journal-title":"Circ. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7823","DOI":"10.1038\/s41598-018-25690-4","article-title":"MicroRNA expression profile of human advanced coronary atherosclerotic plaques","volume":"8","author":"Parahuleva","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.freeradbiomed.2011.09.014","article-title":"Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells","volume":"51","author":"Pulkkinen","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cvr\/cvu070","article-title":"Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis","volume":"103","author":"Tian","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.18632\/aging.102721","article-title":"Targeting of miR-96-5p by catalpol ameliorates oxidative stress and hepatic steatosis in LDLr-\/- mice via p66shc\/cytochrome C cascade","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.110.216770","article-title":"Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21\u2013Dependent Mechanism","volume":"107","author":"Fleissner","year":"2010","journal-title":"Circ. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/2\/262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:40Z","timestamp":1760120080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/2\/262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":129,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["antiox12020262"],"URL":"https:\/\/doi.org\/10.3390\/antiox12020262","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}